Optimizing Outcomes of Treatment-Resistant Depression in Older Adults
Public ClinicalTrials.gov record NCT02960763. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Study identification
- NCT ID
- NCT02960763
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Washington University School of Medicine
- Other
- Enrollment
- 742 participants
Conditions and interventions
Conditions
Interventions
- Aripiprazole Augmentation Drug
- Bupropion Augmentation Drug
- Lithium Augmentation Drug
- Switch to bupropion Drug
- Switch to nortriptyline Drug
Drug
Eligibility (public fields only)
- Age range
- 60 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 23, 2017
- Primary completion
- Sep 27, 2020
- Completion
- Aug 31, 2021
- Last update posted
- Oct 2, 2024
2017 – 2021
United States locations
- U.S. sites
- 4
- U.S. states
- 4
- U.S. cities
- 4
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| UCLA Late-Life Mood, Stress, and Wellness Research Program | Los Angeles | California | 90095 | — |
| Washington University School of Medicine Healthy Mind Lab | St Louis | Missouri | 63110 | — |
| Columbia University Adult and Late Life Depression Clinic | New York | New York | 10032 | — |
| UPMC Late-Life Depression, Evaluation, Prevention, and Treatment Program | Pittsburgh | Pennsylvania | 15213 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02960763, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 2, 2024 · Synced May 12, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02960763 live on ClinicalTrials.gov.